{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:52:19Z","timestamp":1793836339169,"version":"4.6.1"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.intimp.2026.116917","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T21:28:11Z","timestamp":1779830891000},"page":"116917","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Ginsenoside Rh2 inhibits epithelial-mesenchymal transition in triple-negative breast cancer cell via disrupting the HIF-1\u03b1\/YAP nuclear translocation axis"],"prefix":"10.1016","volume":"184","author":[{"given":"Huijuan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guohui","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2026.116917_bb0005","article-title":"Artificial intelligence-based automated breast ultrasound Radiomics for breast tumor diagnosis and treatment: a narrative review","volume":"15","author":"Guo","year":"2025","journal-title":"Front. Oncol."},{"key":"10.1016\/j.intimp.2026.116917_bb0010","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.ejca.2021.07.039","article-title":"The European cancer burden in 2020: incidence and mortality estimates for 40 countries and 25 major cancers","volume":"157","author":"Dyba","year":"2021","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.intimp.2026.116917_bb0015","doi-asserted-by":"crossref","DOI":"10.1038\/s41523-020-0151-5","article-title":"The therapeutic response of Er+\/Her2- breast cancers differs according to the molecular basal or luminal subtype","volume":"6","author":"Bertucci","year":"2020","journal-title":"NPJ Breast Cancer."},{"issue":"6","key":"10.1016\/j.intimp.2026.116917_bb0020","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1021\/jacs.9b10510","article-title":"Molecularly engineering Triptolide with aptamers for high specificity and cytotoxicity for triple-negative breast Cancer","volume":"142","author":"He","year":"2020","journal-title":"J. Am. Chem. Soc."},{"issue":"22","key":"10.1016\/j.intimp.2026.116917_bb0025","doi-asserted-by":"crossref","first-page":"6386","DOI":"10.7150\/thno.29164","article-title":"Genomic landscape and endocrine-resistant subgroup in estrogen receptor-positive, progesterone receptor-negative, and Her2-negative breast Cancer","volume":"8","author":"Liu","year":"2018","journal-title":"Theranostics"},{"issue":"10","key":"10.1016\/j.intimp.2026.116917_bb0030","article-title":"Triple-negative breast cancer: histopathologic features, genomics, and treatment","volume":"43","author":"B.E. European Journal of CancerAdrada","year":"2023","journal-title":"Radiographics"},{"key":"10.1016\/j.intimp.2026.116917_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/CMAR.S316700","article-title":"The characteristics of tumor microenvironment in triple negative breast Cancer","volume":"14","author":"Fan","year":"2022","journal-title":"Cancer Manag. Res."},{"issue":"6","key":"10.1016\/j.intimp.2026.116917_bb0040","doi-asserted-by":"crossref","DOI":"10.3390\/biom13060886","article-title":"Gastric Cancer vascularization and the contribution of reactive oxygen species","volume":"13","author":"Biagioni","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.intimp.2026.116917_bb0045","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1370800","article-title":"Hypoxia-inducible factor in breast Cancer: role and target for breast Cancer treatment","volume":"15","author":"Zhi","year":"2024","journal-title":"Front. Immunol."},{"issue":"Pt 1","key":"10.1016\/j.intimp.2026.116917_bb0050","article-title":"Yap induces Fak phosphorylation to inhibit gastric cancer cell proliferation via upregulation of Hmgb1","volume":"262","author":"Jiang","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116917_bb0055","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1038\/s41467-022-30831-5","article-title":"Yap inhibits Er\u03b1 and Er(+) breast Cancer growth by disrupting a Tead-Er\u03b1 signaling Axis","volume":"13","author":"Li","year":"2022","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.intimp.2026.116917_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.101839","article-title":"Calmodulin activates the hippo signaling pathway by promoting Lats1 kinase-mediated inhibitory phosphorylation of the transcriptional coactivator yap","volume":"298","author":"Thines","year":"2022","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2026.116917_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216635","article-title":"A novel antagonist of the Ccl5\/Ccr5 Axis suppresses the tumor growth and metastasis of triple-negative breast Cancer by Ccr5-Yap1 regulation","volume":"583","author":"Chen","year":"2024","journal-title":"Cancer Lett."},{"issue":"3","key":"10.1016\/j.intimp.2026.116917_bb0070","doi-asserted-by":"crossref","DOI":"10.3390\/cells12030416","article-title":"The role of cytokines in epithelial-mesenchymal transition in gynaecological cancers: a systematic review","volume":"12","author":"Ray","year":"2023","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.intimp.2026.116917_bb0075","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21020404","article-title":"Chemotherapeutic stress influences epithelial-mesenchymal transition and Stemness in Cancer stem cells of triple-negative breast Cancer","volume":"21","author":"Li","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2026.116917_bb0080","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2025.1535563","article-title":"Sodium butyrate and sodium propionate inhibit breast Cancer cell migration and invasion through regulation of epithelial-to-mesenchymal transition and suppression of Mek\/Erk signaling pathway","volume":"13","author":"Kharazi","year":"2025","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.intimp.2026.116917_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.116617","article-title":"Taxifolin inhibits breast Cancer cells proliferation, migration and invasion by promoting mesenchymal to epithelial transition via \u0392-catenin signaling","volume":"232","author":"Li","year":"2019","journal-title":"Life Sci."},{"key":"10.1016\/j.intimp.2026.116917_bb0090","article-title":"Ginsenoside Rh2 regulates triple-negative breast Cancer proliferation and apoptosis via the Il-6\/Jak2\/Stat3 pathway","volume":"15","author":"Ding","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2026.116917_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113912","article-title":"Role of Ginsenoside Rh2 in tumor therapy and tumor microenvironment immunomodulation","volume":"156","author":"Xiaodan","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.intimp.2026.116917_bb0100","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1021\/acs.molpharmaceut.3c00733","article-title":"Immuno-enhancing effect of Ginsenoside Rh2 liposomes on foot-and-mouth disease vaccine","volume":"21","author":"Miao","year":"2024","journal-title":"Mol. Pharm."},{"issue":"21","key":"10.1016\/j.intimp.2026.116917_bb0105","doi-asserted-by":"crossref","DOI":"10.3390\/foods12213946","article-title":"Influence of Auricularia Cornea polysaccharide coating on the stability and antioxidant activity of liposomes Ginsenoside Rh2","volume":"12","author":"Wang","year":"2023","journal-title":"Foods"},{"issue":"1","key":"10.1016\/j.intimp.2026.116917_bb0110","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/ptr.6804","article-title":"Protective effect of Ginsenoside Rh2 on scopolamine-induced memory deficits through regulation of cholinergic transmission, Oxidative Stress and the Erk-Creb-Bdnf Signaling Pathway","volume":"35","author":"Lv","year":"2021","journal-title":"Phytother. Res."},{"issue":"Pt B","key":"10.1016\/j.intimp.2026.116917_bb0115","article-title":"Ginsenoside Rh2 ameliorates pulmonary fibrosis via Hsp70-dependent Autophagic flux regulation and senescence arrest","volume":"353","author":"Zhang","year":"2025","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.intimp.2026.116917_bb0120","article-title":"Ginsenoside Rh2 and its Octyl Ester derivative inhibited invasion and metastasis of hepatocellular carcinoma via the C-Jun\/Cox2\/Pge2 pathway","volume":"121","author":"Hu","year":"2023","journal-title":"Phytomed. Int. J. Phytother. Phytopharm."},{"issue":"12","key":"10.1016\/j.intimp.2026.116917_bb0125","first-page":"881","article-title":"Potential of Ginsenoside Rh2 and its derivatives as anti-Cancer agents","volume":"20","author":"Li","year":"2022","journal-title":"Chin. J. Nat. Med."},{"key":"10.1016\/j.intimp.2026.116917_bb0130","article-title":"Ginsenoside Rh2 enhances immune surveillance of natural killer (Nk) cells via inhibition of Erp5 in breast Cancer","volume":"123","author":"Yang","year":"2024","journal-title":"Phytomed. Int. J. Phytother. Phytopharm."},{"key":"10.1016\/j.intimp.2026.116917_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.115668","article-title":"Curculigoside mediates the Stat3\/Pd-L1 pathway to inhibit the proliferation, Invasion, and Immune Escape of Breast Cancer Cells","volume":"167","author":"Lan","year":"2025","journal-title":"Int. Immunopharmacol."},{"issue":"3","key":"10.1016\/j.intimp.2026.116917_bb0140","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/s41419-022-04647-6","article-title":"Extracellular Atp promotes breast Cancer Chemoresistance via Hif-1\u03b1 signaling","volume":"13","author":"Yang","year":"2022","journal-title":"Cell Death Dis."},{"issue":"9","key":"10.1016\/j.intimp.2026.116917_bb0145","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/s41419-022-05253-2","article-title":"Regulatory mechanisms and function of hypoxia-induced long noncoding Rna Ndrg1-Ot1 in breast Cancer cells","volume":"13","author":"Chao","year":"2022","journal-title":"Cell Death Dis."},{"issue":"7","key":"10.1016\/j.intimp.2026.116917_bb0150","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1002\/ijc.35278","article-title":"The Globocan 2022 Cancer estimates: data sources, methods, and a snapshot of the Cancer Burden worldwide","volume":"156","author":"Filho","year":"2025","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.intimp.2026.116917_bb0155","article-title":"Targeted therapeutic strategies for triple-negative breast Cancer","volume":"11","author":"Li","year":"2021","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116917_bb0160","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s13045-022-01292-6","article-title":"Hypoxia-inducible factors: master regulators of hypoxic tumor immune escape","volume":"15","author":"Wu","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.intimp.2026.116917_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2024.114456","article-title":"Tumor-targeted Nanosystem with hypoxia inducible factor 1\u03b1 inhibition for synergistic chemo-photodynamic therapy against hypoxic tumor","volume":"248","author":"Zeng","year":"2025","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.intimp.2026.116917_bb0170","article-title":"Hypoxia in breast Cancer-scientific translation to therapeutic and diagnostic clinical applications","volume":"11","author":"Zhang","year":"2021","journal-title":"Front. Oncol."},{"issue":"3","key":"10.1016\/j.intimp.2026.116917_bb0175","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1007\/s13577-024-01046-1","article-title":"lactate in breast Cancer cells is associated with evasion of hypoxia-induced cell cycle arrest and adverse patient outcome","volume":"37","author":"Liu","year":"2024","journal-title":"Hum. Cell"},{"issue":"5","key":"10.1016\/j.intimp.2026.116917_bb0180","doi-asserted-by":"crossref","DOI":"10.3390\/cells8050384","article-title":"Protein hydroxylation by hypoxia-inducible factor (Hif) hydroxylases: unique or ubiquitous?","volume":"8","author":"Strowitzki","year":"2019","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.intimp.2026.116917_bb0185","doi-asserted-by":"crossref","first-page":"R32","DOI":"10.1186\/bcr2854","article-title":"Estrogen receptor Beta inhibits transcriptional activity of hypoxia inducible Factor-1 through the downregulation of Arylhydrocarbon receptor nuclear translocator","volume":"13","author":"Lim","year":"2011","journal-title":"Breast Cancer Res."},{"issue":"1","key":"10.1016\/j.intimp.2026.116917_bb0190","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/s12967-023-04031-8","article-title":"Phf6 recruits Bptf to promote Hif-dependent pathway and progression in yap-high breast Cancer","volume":"21","author":"Gao","year":"2023","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.intimp.2026.116917_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2025.177637","article-title":"Trpm4 channels contribute to Adriamycin Chemoresistance in breast Cancer cells","volume":"998","author":"Guo","year":"2025","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.intimp.2026.116917_bb0200","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.bcp.2019.04.026","article-title":"Salinomycin inhibits breast Cancer progression via targeting Hif-1\u03b1\/Vegf mediated tumor angiogenesis in vitro and in vivo","volume":"164","author":"Dewangan","year":"2019","journal-title":"Biochem. Pharmacol."},{"issue":"8","key":"10.1016\/j.intimp.2026.116917_bb0205","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1073\/pnas.1018866109","article-title":"Antiangiogenic agents increase breast Cancer stem cells via the generation of tumor hypoxia","volume":"109","author":"Conley","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.intimp.2026.116917_bb0210","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.biopha.2017.11.137","article-title":"Inhibitory effects of compound Dmbt on hypoxia-induced Vasculogenic mimicry in human breast Cancer","volume":"96","author":"Li","year":"2017","journal-title":"Biomed. Pharmacother."},{"issue":"3","key":"10.1016\/j.intimp.2026.116917_bb0215","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1177\/1358863X18760718","article-title":"Aspirin suppresses components of Lymphangiogenesis and lymphatic vessel remodeling by inhibiting the Nf-\u039ab\/Vcam-1 pathway in human lymphatic endothelial cells","volume":"23","author":"Prangsaengtong","year":"2018","journal-title":"Vasc. Med."},{"key":"10.1016\/j.intimp.2026.116917_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcp.2020.101602","article-title":"Administration with Hyperoside sensitizes breast Cancer cells to paclitaxel by blocking the Tlr4 signaling","volume":"53","author":"Sun","year":"2020","journal-title":"Mol. Cell. Probes"},{"issue":"1","key":"10.1016\/j.intimp.2026.116917_bb0225","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1021\/acs.molpharmaceut.3c00425","article-title":"Docetaxel inhibits epithelial-mesenchymal transition in human mammary cells","volume":"21","author":"Beerkens","year":"2024","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.intimp.2026.116917_bb0230","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.semcancer.2023.10.003","article-title":"From shape-shifting embryonic cells to oncology: the fascinating history of epithelial mesenchymal transition","volume":"96","author":"Akhurst","year":"2023","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.intimp.2026.116917_bb0235","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1146\/annurev-pathol-020117-043854","article-title":"Epithelial mesenchymal transition in tumor metastasis","volume":"13","author":"Mittal","year":"2018","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.intimp.2026.116917_bb0240","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.ijbiomac.2019.02.040","article-title":"A polysaccharide from Hedyotis Diffusa interrupts metastatic potential of lung adenocarcinoma A549 cells by inhibiting Emt via Egfr\/Akt\/Erk signaling pathways","volume":"129","author":"Lin","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116917_bb0245","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/mc.23364","article-title":"Transcriptional repression of E-cadherin in nickel-exposed lung epithelial cells mediated by loss of Sp1 binding at the promoter","volume":"61","author":"Zhang","year":"2022","journal-title":"Mol. Carcinog."},{"issue":"19","key":"10.1016\/j.intimp.2026.116917_bb0250","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13194985","article-title":"Vimentin is at the heart of epithelial mesenchymal transition (Emt) mediated metastasis","volume":"13","author":"Usman","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"11","key":"10.1016\/j.intimp.2026.116917_bb0255","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.1002\/1878-0261.13061","article-title":"Fluid shear stress activates yap to promote epithelial-mesenchymal transition in hepatocellular carcinoma","volume":"15","author":"Yu","year":"2021","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.intimp.2026.116917_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110462","article-title":"Luteolin suppresses epithelial-mesenchymal transition and migration of triple-negative breast Cancer cells by inhibiting yap\/Taz activity","volume":"129","author":"Cao","year":"2020","journal-title":"Biomed. Pharmacother."},{"issue":"10","key":"10.1016\/j.intimp.2026.116917_bb0265","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1007\/s00066-017-1165-2","article-title":"Metastasis of breast Cancer cells to the bone, lung, and lymph nodes promotes resistance to ionizing radiation","volume":"193","author":"Hara","year":"2017","journal-title":"Strahlenther. Onkol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116917_bb0270","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s10020-022-00509-1","article-title":"Fzd7 accelerates hepatic metastases in pancreatic Cancer by strengthening Emt and Stemness associated with Tgf-\u0392\/Smad3 signaling","volume":"28","author":"Zhang","year":"2022","journal-title":"Mol. Med."},{"key":"10.1016\/j.intimp.2026.116917_bb0275","article-title":"Remodeling the tumor immune microenvironment through hydrogel encapsulated G-Rh2 in situ vaccine and systemic immunotherapy","volume":"29","author":"Li","year":"2024","journal-title":"Mater Today Bio."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926007630?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926007630?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:29:50Z","timestamp":1791995390000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576926007630"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":55,"alternative-id":["S1567576926007630"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2026.116917","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ginsenoside Rh2 inhibits epithelial-mesenchymal transition in triple-negative breast cancer cell via disrupting the HIF-1\u03b1\/YAP nuclear translocation axis","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2026.116917","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"116917"}}